AVALO THERAPEUTICS, INC.

Profile

Company Names

AVALO THERAPEUTICS, INC.
CERECOR INC.

Addresses

540 GAITHER ROAD, SUITE 400, ROCKVILLE, MD 20850

400 EAST PRATT STREET, SUITE 606, BALTIMORE, MD 21202

400 E. PRATT ST., SUITE 606, BALTIMORE, MD 21202

2400 BOSTON STREET, SUITE 324, BALTIMORE, MD 21224

2400 BOSTON STREET, SUITE 324, BALTIMORE, MD 21224

Phone Numbers

410-522-8707

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$181,804,186.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2024-03-27 
$130,601,986.00 
$199,976,986.00 
$69,375,000.00 
Equity 
5
2017-04-27 
$5,000,000.00 
$5,000,000.00 
$0.00 
 
4
2016-09-08 
$1,000,000.00 
$15,000,000.00 
$14,000,000.00 
Equity 
3
2014-07-11 
$16,259,016.00 
$33,259,016.00 
$17,000,000.00 
Equity, Debt 
2
2013-08-23 
$6,805,883.00 
$10,000,000.00 
$3,194,117.00 
Equity 
1
2012-03-23 
$22,137,301.00 
$22,500,000.00 
$362,699.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
 
AASEN 
DIRECTOR
CERECOR INC.   |  EVECXIA, INC.
JUNE 
 
ALMENOFF, M.D., PH.D. 
DIRECTOR
AVALO THERAPEUTICS, INC.
SOL 
 
BARER 
DIRECTOR
CONTRAFECT CORP   |  INSPIREMD, INC.   |  CERECOR INC.   |  EDGE THERAPEUTICS, INC.   |  MIG IRC, LLC   |  CENTREXION CORP   |  RESTORGENEX CORP   |  CENTREXION THERAPEUTICS CORP   |  AMICUS THERAPEUTICS INC   |  ZEPHYR AI, INC.
SOL 
J. 
BARER 
DIRECTOR
AMICUS THERAPEUTICS INC   |  INSPIREMD, INC.   |  EDGE THERAPEUTICS, INC.   |  CERECOR INC.   |  MEDGENICS, INC.   |  CENTREXION THERAPEUTICS CORP   |  AEVI GENOMIC MEDICINE, INC.
EUGENE 
 
BAUER 
DIRECTOR
AVC ROYALTY FUND I, LLC   |  DR. TATTOFF, INC.   |  VYTERIS, INC.   |  CERECOR INC.   |  KADMON HOLDINGS, LLC   |  DERMIRA, INC.   |  EVOMMUNE, INC.
EUGENE 
A. 
BAUER 
DIRECTOR
MEDISYNC BIOSERVICES INC   |  DR. TATTOFF, INC.   |  CERECOR INC.   |  DERMIRA, INC.   |  APPLIED UV, INC.
ISAAC 
 
BLECH 
DIRECTOR
SOCIALWISE, INC. (FORMERLY KNOWN AS IDEAEDGE, INC)   |  CONTRAFECT CORP   |  BILLMYPARENTS, INC.   |  CERECOR INC.   |  MEDGENICS, INC.   |  PREMIER ALLIANCE GROUP, INC.   |  EDGE THERAPEUTICS, INC.   |  SPENDSMART PAYMENTS CO   |  CENTREXION CORP   |  RESTORGENEX CORP   |  ROOT9B TECHNOLOGIES INC.   |  WAVEGUIDE CORP   |  X4 PHARMACEUTICALS, INC.   |  ROOT9B TECHNOLOGIES, INC.   |  INSPIREMD, INC.   |  CENTREXION THERAPEUTICS CORP   |  SAPIENCE THERAPEUTICS, INC.   |  ARIDIS PHARMACEUTICALS, INC.   |  X-VAX TECHNOLOGY, INC.   |  REGENOVATION, INC.   |  DIFFUSION PHARMACEUTICALS INC.   |  NACUITY PHARMACEUTICALS, INC.   |  ELUCIDA ONCOLOGY, INC.   |  MARINA BIOTECH, INC.   |  ALVEO TECHNOLOGIES INC.   |  VEDANTRA PHARMACEUTICALS, INC.
JOHN 
 
CATSIMATIDIS 
DIRECTOR
CERECOR INC.   |  PREMIER ALLIANCE GROUP, INC.   |  ROOT9B TECHNOLOGIES INC.   |  ROOT9B TECHNOLOGIES, INC.
MITCHELL 
 
CHAN 
DIRECTOR
AVALO THERAPEUTICS, INC.
BERNADINE 
HEATHER 
FRASER 
EXECUTIVE OFFICER
CERECOR INC.
JONATHAN 
 
GOLDMAN, M.D. 
DIRECTOR
AVALO THERAPEUTICS, INC.
PHIL 
 
GUTRY 
DIRECTOR
AMPHIVENA THERAPEUTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  CERECOR INC.
ULI 
 
HACKSELL 
EXECUTIVE OFFICER, DIRECTOR
ACADIA PHARMACEUTICALS INC   |  CERECOR INC.   |  MARINA BIOTECH, INC.   |  ADHERA THERAPEUTICS, INC.
JOHN 
 
KAISER 
EXECUTIVE OFFICER
CARENA INC   |  CERECOR INC.   |  EVECXIA, INC.
AARON 
 
KANTOFF 
DIRECTOR
CURE FORWARD CORP.   |  SYNTIMMUNE, INC.   |  CORVIDIA THERAPEUTICS, INC.   |  AKERO THERAPEUTICS, INC.   |  RAYZEBIO, INC.   |  CEPTUR THERAPEUTICS, INC.   |  PETRICHOR SCION THERAPEUTICS LLC   |  AVALO THERAPEUTICS, INC.
GILLA 
 
KAPLAN, PH.D. 
DIRECTOR
TYRA BIOSCIENCES, INC.   |  AVALO THERAPEUTICS, INC.
KAREN 
 
KRUMEICH 
EXECUTIVE OFFICER
CERECOR INC.   |  SOLIGENIX, INC.   |  KAZIA THERAPEUTICS LTD
RONALD 
 
MARCUS 
EXECUTIVE OFFICER
CERECOR INC.
REZA 
 
MAZHARI 
EXECUTIVE OFFICER
CARDIOXYL PHARMACEUTICALS INC   |  CERECOR INC.
MARIAM 
 
MORRIS 
EXECUTIVE OFFICER
CERECOR INC.   |  INSTIL BIO, INC.
MARIAM 
E 
MORRIS 
EXECUTIVE OFFICER
CERECOR INC.
GARRY 
 
NEIL, M.D. 
EXECUTIVE OFFICER, DIRECTOR
AVALO THERAPEUTICS, INC.
FEDERICA 
F. 
O-BRIEN 
EXECUTIVE OFFICER
CERECOR INC.
BLAKE 
M. 
PATERSON 
EXECUTIVE OFFICER, DIRECTOR
CERECOR INC.
MAGNUS 
 
PERSSON 
DIRECTOR
CARMOT THERAPEUTICS INC.   |  CERECOR INC.   |  GOLDCUP 12446 AB   |  TRAILHEAD BIOSYSTEMS INC.
MAGNUS 
 
PERSSON, M.D., PH.D. 
DIRECTOR
COLUMN GROUP II, LP   |  AVALO THERAPEUTICS, INC.
SHARON 
 
ROWLAND 
EXECUTIVE OFFICER
CERECOR INC.
BEHSHAD 
 
SHELDON 
DIRECTOR
CERECOR INC.   |  MAXONA PHARMACEUTICALS, INC.   |  POCKET NALOXONE CORP.
CARY 
 
SUCOFF 
DIRECTOR
BILLMYPARENTS, INC.   |  CERECOR INC.   |  AMERICAN ROADSIDE BURGERS, INC.   |  SPENDSMART PAYMENTS CO   |  CONTRAFECT CORP   |  PREMIER ALLIANCE GROUP, INC.   |  ROOT9B TECHNOLOGIES INC.   |  ROOT9B TECHNOLOGIES, INC.   |  CURATIVE BIOTECHNOLOGY INC
CARY 
W. 
SUCOFF, JR. 
DIRECTOR
CERECOR INC.
MAYUKH 
 
SUKHATME 
DIRECTOR
CERECOR INC.
CHRISTOPHER 
 
SULLIVAN 
EXECUTIVE OFFICER
SECOND ROTATION INC   |  RUME INC.   |  CHK MID-CON CO-INVEST VEHICLE ROYALTY LP   |  GSO GIANT CO-INVEST II LP   |  GSO GIANT CO-INVEST I LP   |  FORELAND RESOURCES HOLDINGS LP   |  GSO FORELAND RESOURCES CO-INVEST HOLDINGS LP   |  GSO CAPITAL SOLUTIONS FUND II LP   |  GSO CAPITAL SOLUTIONS OVERSEAS FEEDER FUND II LP   |  GSO BAKKEN OVERSEAS HOLDINGS I LP   |  GSO BAKKEN HOLDINGS I LP   |  HYPERION CAPITAL PARTNERS VOLATILITY ARBITRAGE FUND, LLC   |  GAZELLE, INC.   |  HYPERION CAPITAL PARTNERS HELIOS FUND, LLC   |  CLARUS PARENT HOLDINGS, LLC   |  AVALO THERAPEUTICS, INC.   |  RIMROCK TOTAL RETURN STRATEGIES FUND, LTD.
FRANK 
 
TORTI 
DIRECTOR
CERECOR INC.   |  GALERA THERAPEUTICS, INC.   |  TARVEDA THERAPEUTICS, INC.   |  ORPHOMED, INC.   |  EARGO, INC.   |  XOC PHARMACEUTICALS, INC.   |  EARLENS CORP   |  ARBUTUS BIOPHARMA CORP   |  IMMUNOVANT, INC.
SAMANTHA 
 
TRUEX 
DIRECTOR
AVALO THERAPEUTICS, INC.
JAMES 
 
VORNOV 
EXECUTIVE OFFICER
CERECOR INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-03-27 
2017-05-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2017-04-27 
2016-09-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-09-08 
2014-07-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-07-11 
2013-09-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-23 
2012-04-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
OPPENHEIMER + CO. INC.
249
NONE
NONE
TROUT CAPITAL LLC
131489
NONE
NONE
MAXIM GROUP, LLC
120708
NA
NONE
MAXIM GROUP LLC
120708